Canntab Therapeutics Limited
CTABF
$0.00
$0.000.00%
OTC PK
| 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.40K | 40.90K | 111.00K | 546.00K | 1.18M |
| Total Receivables | 23.60K | 14.70K | 188.40K | 165.70K | 157.30K |
| Inventory | 211.10K | 355.40K | 438.00K | 386.50K | 1.22M |
| Prepaid Expenses | -- | 20.70K | 50.60K | 58.90K | 47.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 247.00K | 431.70K | 788.10K | 1.16M | 2.61M |
|
|
|||||
| Total Current Assets | 247.00K | 431.70K | 788.10K | 1.16M | 2.61M |
| Net Property, Plant & Equipment | 251.10K | 566.10K | 707.40K | 856.10K | 1.32M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 202.70K | 214.60K | 222.60K | 240.00K | 240.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 700.80K | 1.21M | 1.72M | 2.25M | 4.17M |
|
|
|||||
| Total Accounts Payable | 149.60K | 139.20K | 96.40K | 127.10K | 194.90K |
| Total Accrued Expenses | 741.30K | 652.80K | 662.50K | 637.30K | 557.60K |
| Short-term Debt | 44.10K | 44.30K | 45.90K | 47.40K | 47.40K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.35M | 1.21M | 1.17M | 1.15M | 1.09M |
| Total Finance Division Other Current Liabilities | 3.70K | 57.60K | 12.60K | 61.00K | 295.20K |
| Total Other Current Liabilities | 3.70K | 57.60K | 12.60K | 61.00K | 295.20K |
| Total Current Liabilities | 2.29M | 2.10M | 1.99M | 2.02M | 2.18M |
|
|
|||||
| Total Current Liabilities | 2.29M | 2.10M | 1.99M | 2.02M | 2.18M |
| Long-Term Debt | -- | 142.90K | 116.10K | 99.70K | 717.60K |
| Short-term Debt | 44.10K | 44.30K | 45.90K | 47.40K | 47.40K |
| Capital Leases | -- | 112.70K | 135.60K | 159.20K | 176.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 148.20K | 34.60K | 219.70K | 266.90K |
| Total Liabilities | 2.29M | 2.50M | 2.28M | 2.50M | 3.34M |
|
|
|||||
| Common Stock & APIC | 12.09M | 12.15M | 12.57M | 12.95M | 12.87M |
| Retained Earnings | -13.68M | -13.44M | -13.13M | -13.19M | -12.04M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1.59M | -1.29M | -560.30K | -245.90K | 833.10K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.59M | -1.29M | -560.30K | -245.90K | 833.10K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.59M | -1.29M | -560.30K | -245.90K | 833.10K |
|
|
|||||